Independent Investors Inc’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.81M | Hold |
17,900
| – | – | 0.54% | 26 |
|
|
2026
Q1 | $2.73M | Hold |
17,900
| – | – | 0.54% | 29 |
|
|
2025
Q4 | $2.47M | Hold |
17,900
| – | – | 0.46% | 31 |
|
|
2025
Q3 | $2.3M | Hold |
17,900
| – | – | 0.44% | 32 |
|
|
2025
Q2 | $2.17M | Hold |
17,900
| – | – | 0.47% | 33 |
|
|
2025
Q1 | $2M | Hold |
17,900
| – | – | 0.42% | 32 |
|
|
2024
Q4 | $1.74M | Hold |
17,900
| – | – | 0.34% | 34 |
|
|
2024
Q3 | $2.06M | Hold |
17,900
| – | – | 0.42% | 32 |
|
|
2024
Q2 | $1.91M | Hold |
17,900
| – | – | 0.42% | 32 |
|
|
2024
Q1 | $1.73M | Hold |
17,900
| – | – | 0.41% | 33 |
|
|
2023
Q4 | $1.81M | Hold |
17,900
| – | – | 0.42% | 33 |
|
|
2023
Q3 | $1.82M | Hold |
17,900
| – | – | 0.46% | 28 |
|
|
2023
Q2 | $1.81M | Hold |
17,900
| – | – | 0.42% | 31 |
|
|
2023
Q1 | $1.65M | Hold |
17,900
| – | – | 0.41% | 34 |
|
|
2022
Q4 | $1.62M | Hold |
17,900
| – | – | 0.45% | 34 |
|
|
2022
Q3 | $1.36M | Hold |
17,900
| – | – | 0.39% | 38 |
|
|
2022
Q2 | $1.51M | Hold |
17,900
| – | – | 0.41% | 36 |
|
|
2022
Q1 | $1.57M | Hold |
17,900
| – | – | 0.35% | 38 |
|
|
2021
Q4 | $1.57M | Hold |
17,900
| – | – | 0.33% | 38 |
|
|
2021
Q3 | $1.46M | Hold |
17,900
| – | – | 0.36% | 40 |
|
|
2021
Q2 | $1.63M | Hold |
17,900
| – | – | 0.4% | 37 |
|
|
2021
Q1 | $1.53M | Hold |
17,900
| – | – | 0.41% | 39 |
|
|
2020
Q4 | $1.69M | Hold |
17,900
| – | – | 0.45% | 36 |
|
|
2020
Q3 | $1.56M | Hold |
17,900
| – | – | 0.45% | 36 |
|
|
2020
Q2 | $1.56M | Hold |
17,900
| – | – | 0.53% | 36 |
|
|
2020
Q1 | $1.48M | Hold |
17,900
| – | – | 0.61% | 36 |
|
|
2019
Q4 | $1.69M | Hold |
17,900
| – | – | 0.56% | 36 |
|
|
2019
Q3 | $1.55M | Hold |
17,900
| – | – | 0.58% | 37 |
|
|
2019
Q2 | $1.63M | Sell |
17,900
-2,076
| -10% | -$176K | 0.63% | 36 |
|
|
2019
Q1 | $1.72M | Hold |
19,976
| – | – | 0.67% | 33 |
|
|
2018
Q4 | $1.53M | Hold |
19,976
| – | – | 0.67% | 35 |
|
|
2018
Q3 | $1.54M | Hold |
19,976
| – | – | 0.54% | 42 |
|
|
2018
Q2 | $1.35M | Hold |
19,976
| – | – | 0.53% | 42 |
|
|
2018
Q1 | $1.45M | Hold |
19,976
| – | – | 0.58% | 41 |
|
|
2017
Q4 | $1.5M | Hold |
19,976
| – | – | 0.58% | 42 |
|
|
2017
Q3 | $1.54M | Hold |
19,976
| – | – | 0.64% | 40 |
|
|
2017
Q2 | $1.49M | Sell |
19,976
-447
| -2% | -$31.7K | 0.65% | 39 |
|
|
2017
Q1 | $1.36M | Sell |
20,423
-4,464
| -18% | -$297K | 0.58% | 41 |
|
|
2016
Q4 | $1.62M | Hold |
24,887
| – | – | 0.75% | 36 |
|
|
2016
Q3 | $1.76M | Hold |
24,887
| – | – | 0.81% | 33 |
|
|
2016
Q2 | $1.84M | Hold |
24,887
| – | – | 0.89% | 31 |
|
|
2016
Q1 | $1.61M | Sell |
24,887
-223
| -0.9% | -$15.2K | 0.78% | 33 |
|
|
2015
Q4 | $1.94M | Buy |
25,110
+112
| +0.4% | +$8.9K | 0.94% | 31 |
|
|
2015
Q3 | $2.06M | Hold |
24,998
| – | – | 1.02% | 30 |
|
|
2015
Q2 | $2.2M | Hold |
24,998
| – | – | 1% | 31 |
|
|
2015
Q1 | $2.21M | Hold |
24,998
| – | – | 1% | 32 |
|
|
2014
Q4 | $2.08M | Hold |
24,998
| – | – | 0.91% | 35 |
|
|
2014
Q3 | $2.11M | Hold |
24,998
| – | – | 0.95% | 32 |
|
|
2014
Q2 | $2.03M | Hold |
24,998
| – | – | 0.92% | 36 |
|
|
2014
Q1 | $1.9M | Sell |
24,998
-670
| -3% | -$48.8K | 0.92% | 36 |
|
|
2013
Q4 | $1.85M | Sell |
25,668
-1,674
| -6% | -$116K | 0.89% | 35 |
|
|
2013
Q3 | $1.88M | Sell |
27,342
-446
| -2% | -$29.5K | 0.99% | 35 |
|
|
2013
Q2 | $1.76M | Buy |
+27,788
| New | +$1.81M | 0.97% | 32 |
|
Other funds holding NVS
Independent Investors Inc's NVS Position: Q2 2026 in Review
Independent Investors Inc held its Novartis (NVS) position steady in Q2 2026 at 17,900 shares worth $2.81M. The position accounts for 0.54% of the portfolio, ranked #26.
Independent Investors Inc first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. 1,546 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Independent Investors Inc held 17,900 shares of Novartis worth $2.81M as of Q2 2026.
- Independent Investors Inc left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.54% of Independent Investors Inc's portfolio in Q2 2026, its #26 holding.
- Independent Investors Inc first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- 1,546 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Independent Investors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.